209 related articles for article (PubMed ID: 32461343)
1. Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response.
LaSalle T; Austin EE; Rigney G; Wehrenberg-Klee E; Nesti S; Larimer B; Mahmood U
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461343
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.
Larimer BM; Wehrenberg-Klee E; Dubois F; Mehta A; Kalomeris T; Flaherty K; Boland G; Mahmood U
Cancer Res; 2017 May; 77(9):2318-2327. PubMed ID: 28461564
[TBL] [Abstract][Full Text] [Related]
3. Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.
Goggi JL; Hartimath SV; Xuan TY; Khanapur S; Jieu B; Chin HX; Ramasamy B; Cheng P; Rong TJ; Fong YF; Yuen TY; Msallam R; Chacko AM; Renia L; Johannes C; Hwang YY; Robins EG
Mol Imaging Biol; 2021 Oct; 23(5):714-723. PubMed ID: 33713000
[TBL] [Abstract][Full Text] [Related]
4. A Novel Translational PET Imaging Approach to Quantifying Distal Tumor Immune Activation After Targeted Radiation Therapy and Checkpoint Blockade.
Zhang Y; Deshane JS; Yang ES; Larimer B
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1217-1227. PubMed ID: 38199384
[TBL] [Abstract][Full Text] [Related]
5. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
6. Examining Immunotherapy Response Using Multiple Radiotracers.
Goggi JL; Hartimath SV; Hwang Y; Tan YX; Khanapur S; Ramasamy B; Jiang L; Yong FF; Cheng P; Tan PW; Husaini MA; Yuen TY; Jieu B; Chacko AM; Larbi A; Renia L; Johannes C; Robins EG
Mol Imaging Biol; 2020 Aug; 22(4):993-1002. PubMed ID: 32006204
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
[No Abstract] [Full Text] [Related]
8. Granzyme B PET Imaging of the Innate Immune Response.
Capaccione KM; Doubrovin M; Bhatt N; Mintz A; Molotkov A
Molecules; 2020 Jul; 25(13):. PubMed ID: 32646038
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging.
Larimer BM; Bloch E; Nesti S; Austin EE; Wehrenberg-Klee E; Boland G; Mahmood U
Clin Cancer Res; 2019 Feb; 25(4):1196-1205. PubMed ID: 30327313
[TBL] [Abstract][Full Text] [Related]
10. Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes.
Goggi JL; Tan YX; Hartimath SV; Jieu B; Hwang YY; Jiang L; Boominathan R; Cheng P; Yuen TY; Chin HX; Tang JR; Larbi A; Chacko AM; Renia L; Johannes C; Robins EG
Mol Imaging Biol; 2020 Oct; 22(5):1392-1402. PubMed ID: 32705455
[TBL] [Abstract][Full Text] [Related]
11. PET Imaging for Monitoring Cellular and Immunotherapy of Cancer.
Larimer BM
Cancer J; 2024 May-Jun 01; 30(3):153-158. PubMed ID: 38753749
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy.
Zhou H; Wang Y; Xu H; Shen X; Zhang T; Zhou X; Zeng Y; Li K; Zhang L; Zhu H; Yang X; Li N; Yang Z; Liu Z
J Clin Invest; 2022 Aug; 132(16):. PubMed ID: 35788116
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive Detection of Immunotherapy-Induced Adverse Events.
Ferreira CA; Heidari P; Ataeinia B; Sinevici N; Sise ME; Colvin RB; Wehrenberg-Klee E; Mahmood U
Clin Cancer Res; 2021 Oct; 27(19):5353-5364. PubMed ID: 34253581
[TBL] [Abstract][Full Text] [Related]
14. Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?
Verhoeff SR; van den Heuvel MM; van Herpen CML; Piet B; Aarntzen EHJG; Heskamp S
PET Clin; 2020 Jan; 15(1):35-43. PubMed ID: 31735300
[TBL] [Abstract][Full Text] [Related]
15. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
[TBL] [Abstract][Full Text] [Related]
16. In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy.
Chen M; Zhou K; Dai SY; Tadepalli S; Balakrishnan PB; Xie J; Rami FEI; Dai T; Cui L; Idoyaga J; Rao J
Cell Chem Biol; 2022 Oct; 29(10):1556-1567.e6. PubMed ID: 36103874
[TBL] [Abstract][Full Text] [Related]
17. Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy.
Nguyen A; Ramesh A; Kumar S; Nandi D; Brouillard A; Wells A; Pobezinsky L; Osborne B; Kulkarni AA
Sci Adv; 2020 Oct; 6(40):. PubMed ID: 33008894
[TBL] [Abstract][Full Text] [Related]
18. The role of PET in imaging of the tumour microenvironment and response to immunotherapy.
Lilburn DML; Groves AM
Clin Radiol; 2021 Oct; 76(10):784.e1-784.e15. PubMed ID: 34503671
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies.
Friedman J; Morisada M; Sun L; Moore EC; Padget M; Hodge JW; Schlom J; Gameiro SR; Allen CT
J Immunother Cancer; 2018 Jun; 6(1):59. PubMed ID: 29925431
[TBL] [Abstract][Full Text] [Related]
20. Monitoring CD8a
Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
